Modified pectin

Details Modified pectin Modified pectin

1993-03-01

2009-02-17

Lewis, Patrick T (Department: 1623)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

C536S123100, C536S124000, C536S126000, C536S127000, C435S032000, C435S101000

Reexamination Certificate

active

07491708

ABSTRACT:
A modified pectin consists essentially of neutral sugar sequences with a low degree of branching capable of preventing tumor cell migration and cell to cell and cell to substratum adhesion.

REFERENCES:
patent: 2444266 (1948-06-01), Owens et al.
patent: 4016351 (1977-04-01), Eschinasi
patent: 143 261 (1980-08-01), None
patent: 143261 (1980-08-01), None
patent: 39039C22 (1980-04-01), None
patent: 39039C/22 (1980-04-01), None
patent: 88 51 50094/22 (1988-04-01), None
patent: 88-150094/22 (1988-04-01), None
patent: 88515009422 (1988-04-01), None
Platt et al,Journal of the National Cancer Institute, vol. 84, No. 6, Mar. 18, 1992.
Mueller et al,Chemical Abstracts, vol. 110, p. 44, Ref. # 165780g, 1989 (Immunopharmacology 1989, 17(1), 11-18).
Hosoda et al,Chemical Abstracts, vol. 110, p. 635, Ref. #6827 m, 1989.
Neff et al,Plant Physiol., vol. 83, pp. 525-528, 1987.
Curti,Critical Reviews on Oncology/Hematology, vol. 14, pp. 29-39, 1993.
Osbaud et al,Immunology Today, vol. 11, No. 6, pp. 103-105, 1990.
Trott, “Differences between mouse and human tumors that effect their responses to radiotherapy” Edited by Kullman,Pregamon Press, pp. 6-11, 1987.
Seiman, Satisfactory and Unsatisfactory tumor models Factors influencing the selection of a tumor model for experimental evaluation; Edited by Kullman,Pergamon Press, pp. 12-15, 1987.
Jain,Scientific America, pp. 58-65, Jul. 1994.
Fidler,Cancer Research, vol. 35, pp. 218-224, 1975.
Dumont et al,Cancer Research, vol. 52, pp. 1195-1200, Mar. 1, 1992.
Schultz et al,Cancer Research, vol. 48, pp. 5539-5545, Oct. 1, 1988.
Finne et al,Int. J. Cancer, vol. 43, pp. 300-304, 1989.
Devita et al., Cancer: Principles & Practice of Oncology, 5th edition, Chapter 7, pp. 139, 143-146 (1997).
Beuth et al. Clin. Expl. Metastasis (1988), vol. 6, pp. 115-120.
Journal of the National Cancer Institute, vol. 84, No. 6. Mar. 18, 1992; Platt et al. “Modulation of the Lung Colonization of B16-F1 Melanoma Cells by Citrus Pectin”.

Affiliated with

Also associated with

Rating

Modified pectin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Modified pectin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified pectin will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4083361